Journal of Applied Pharmacy

Journal of Applied Pharmacy
Open Access

ISSN: 1920-4159



Kanza Ijaz, Omer B., Mehmood K.T.

Hepatitis is a disease characterized by inflammation of the liver, usually producing swelling and damage to liver tissues. The hepatitis C virus causes hepatitis C. A marked reduction in the quality of life of hepatitis C patients has been revealed in a number of studies conducted worldwide. A retrospective study was carried out among hundred patients of hepatitis C and three of them were followed for a period of 3months. The major aims of this study were to evaluate the quality of life of the patients suffering from hepatitis C, estimation of the patient compliance with the management methods, evaluation of the end results of the therapeutic treatment, assessment of the patient satisfaction with the medicines, comparison of the quality of life of the suffering patients with their optimum health state and the comparison of the quality of life of the patients during and after the management/treatment of the disease. In order to follow the study, a medication history/patient interview form was developed on the basis of which patients suffering from hepatitis C were interviewed. This survey was followed by the comparison of national treatment guidelines with international treatment guidelines. The study revealed that the patients were not satisfied with their quality of life during their ailment whereas many expressed that their quality of life improved after receiving a rational and well managed medical treatment.